Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Placebo Evaluate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03845023
What this trial is testing

Trial of AD036 in Obstructive Sleep Apnea

Who this might be right for
Obstructive Sleep Apnea
Apnimed 140
Large-scale testing (Phase 3)Study completedNCT00520780
What this trial is testing

Ferinject® Assessment in Patients With Iron Deficiency and Chronic Heart Failure (FAIR-HF)

Who this might be right for
Chronic Heart FailureIron DeficiencyIron Deficiency Anemia+1 more
Vifor Pharma 456
Early research (Phase 1)Study completedNCT01370317
What this trial is testing

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MK-1029 in Participants With Mild to Moderate Asthma

Who this might be right for
Asthma
Merck Sharp & Dohme LLC 27
Testing effectiveness (Phase 2)Study completedNCT05185089
What this trial is testing

Efficacy and Safety Study of Orvepitant for Chronic Cough in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
CoughIdiopathic Pulmonary Fibrosis
Nerre Therapeutics Ltd. 80
Large-scale testing (Phase 3)Not Yet RecruitingNCT07730840
What this trial is testing

Zastaprazan for the prEvention of Upper GI Bleeding in Ischemic Stroke

Who this might be right for
Ischemic StrokeTransient Ischemic Attack
Asan Medical Center 984
Early research (Phase 1)Not Yet RecruitingNCT07634510
What this trial is testing

Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MWX205

Who this might be right for
Dyslipidemias
Shanghai Minwei Biotechnology Co., Ltd 37
Testing effectiveness (Phase 2)Study completedNCT06732960
What this trial is testing

The Efficacy and Safety of Efsubaglutide Alfa in Overweight or Obesity Patients

Who this might be right for
Overweight or Obesity
Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. 50
Early research (Phase 1)Study completedNCT02222324
What this trial is testing

Evaluate the Effects of E2609 on QTc Interval in Healthy Subjects

Who this might be right for
Healthy Subjects
Eisai Inc. 60
Testing effectiveness (Phase 2)Looking for participantsNCT07671924
What this trial is testing

The Effect of Nalbuphine Extended-Release (NAL ER) on Cough in Participants With Refractory Chronic Cough (RCC)

Who this might be right for
Refractory Chronic Cough
Trevi Therapeutics 100
Testing effectiveness (Phase 2)Study completedNCT00297180
What this trial is testing

Weight Loss In Obese Subjects Taking Either GW869682 Or Placebo 3 Times Per Day For 12 Weeks

Who this might be right for
Obesity
GlaxoSmithKline 136
Early research (Phase 1)Study completedNCT02877979
What this trial is testing

Evaluate the Safety & Assess Local and Systemic PK of DS003 Vaginal Tablets Administered to Healthy HIV-negative Women

Who this might be right for
HIV
International Partnership for Microbicides, Inc. 36
Large-scale testing (Phase 3)Study completedNCT03726879
What this trial is testing

Evaluate the Efficacy and Safety Of Atezolizumab or Placebo in Combination With Neoadjuvant Doxorubicin + Cyclophosphamide Followed By Paclitaxel + Trastuzumab + Pertuzumab In Early Her2-Positive Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 454
Large-scale testing (Phase 3)Study completedNCT04218162
What this trial is testing

Lasmiditan Compared to Placebo in the Acute Treatment of Migraine in Korean

Who this might be right for
Acute Migraine
IlDong Pharmaceutical Co Ltd 294
Early research (Phase 1)Study completedNCT02531685
What this trial is testing

Phase 1 Study of dmLT ID Vaccination in Healthy Adults

Who this might be right for
Gastroenteritis Escherichia Coli
National Institute of Allergy and Infectious Diseases (NIAID) 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07754825
What this trial is testing

A Phase II Clinical Study of LT3001 for Injection in the Treatment of Acute Ischemic Stroke

Who this might be right for
Acute Ischemic Stroke
Shanghai Pharmaceuticals Holding Co., Ltd 300
Large-scale testing (Phase 3)Active Not RecruitingNCT06291376
What this trial is testing

Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)

Who this might be right for
Immunoglobulin A NephropathyIgAN
Alexion Pharmaceuticals, Inc. 579
Testing effectiveness (Phase 2)Looking for participantsNCT06197568
What this trial is testing

Proof of Concept Study of Vaginal AZU-101 in Vulvovaginal Atrophy in Postmenopausal Women

Who this might be right for
Vulvo Vaginal Atrophy (VVA)
Azure Biotech Inc. 90
Large-scale testing (Phase 3)Ended earlyNCT03710291
What this trial is testing

Evaluation of Effect of TRC101 on Progression of Chronic Kidney Disease in Subjects With Metabolic Acidosis

Who this might be right for
Metabolic AcidosisChronic Kidney Disease
Tricida, Inc. 1,480
Large-scale testing (Phase 3)UnknownNCT02130882
What this trial is testing

Study to Evaluate Safety and Efficacy of Benralizumab in Subjects With Hypereosinophilic Syndrome

Who this might be right for
Respiratory System AgentsAnti-Asthmatic AgentsHematologic Diseases+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 20
Large-scale testing (Phase 3)Active Not RecruitingNCT04765059
What this trial is testing

Evaluate Chemotherapy Plus Osimertinib Against Chemotherapy Plus Placebo in Patients With Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
AstraZeneca 98
Next Page